#USA #Philadelphia #RWE #HealthVerity #ClaritasRx

HealthVerity and Claritas Rx Join Forces for Real-World Data Insights

In a groundbreaking move set to revolutionize the pharmaceutical industry, HealthVerity, recognized as the leader in real-world data (RWD) technology, has announced a strategic partnership with Claritas Rx, experts in optimizing patient journeys. This alliance, unveiled on October 20, 2025, aims to deliver a new data-centric offering that significantly enhances visibility and real-world evidence (RWE) across the pharmaceutical product lifecycle.

Both companies bring unique strengths to the table: HealthVerity with its vast repository of de-identified RWD, including medical and pharmacy claims, electronic medical records (EMR), and laboratory data, and Claritas Rx, which specializes in data pertinent to specialty pharmacy, hub, and co-pay programs. This partnership charted a course toward providing pharmaceutical manufacturers an integrated and privacy-secure dataset, designed to deliver unparalleled insights into treatment accessibility, time-to-therapy, and patient adherence.

For commercial teams, the implications are profound. A clearer understanding of brand performance is essential for making optimized targeting and strategic access decisions. Furthermore, the collaboration offers RWE and Health Economics and Outcomes Research (HEOR) leaders an enhanced mechanism for generating evidence more swiftly and accurately, by bridging critical gaps in the understanding of patient journeys. This, in turn, enables longitudinal analysis from the point of prescription right through to patient outcomes.

Andrew Goldberg, Chief Operating Officer and co-founder of HealthVerity, points to the increased pressure faced by pharmaceutical companies today to illustrate effectiveness and value using real-world data. He stated, "This partnership gives our clients the depth and flexibility they need to do exactly that. By merging our Verified data ecosystem with the specialty data expertise from Claritas Rx, we can provide much greater coverage, precision, and stability—elements vital for real-time decision-making."

Michael Fitzgibbons, CEO of Claritas Rx, echoed this sentiment, expressing enthusiasm about the new collaboration: "We are thrilled to work with HealthVerity to meet the growing demand for integrated, actionable patient data. Combining our expertise in specialty data with HealthVerity’s scalable infrastructure empowers commercial, RWE, and HEOR teams with a comprehensive 360-degree view of unique patient behavior and treatment dynamics."

The impact of this partnership is multifaceted. By enabling faster access for pharmaceutical customers to the Claritas Rx specialty aggregation platform and its analytics capabilities, stakeholders—ranging from brand and commercial strategy teams to HEOR and RWE researchers—will gain unprecedented insights. This can drastically improve decision-making processes across leading life sciences organizations.

As the healthcare landscape continues to evolve and the demand for actionable insights rises, this collaboration between HealthVerity and Claritas Rx marks a significant step forward. It symbolizes a commitment to addressing the complex challenges faced within the pharmaceutical sector by leveraging an integrated data approach that prioritizes patient accessibility and adherence to treatment regimens.

To learn more about this groundbreaking partnership or to explore the new data-driven offerings it entails, interested parties can find further information via HealthVerity and Claritas Rx channels.

About HealthVerity

HealthVerity stands at the forefront of privacy-protected real-world data exchange, altering the manner in which healthcare and life sciences organizations connect and analyze diverse patient data. Their platform enables access to a comprehensive RWD ecosystem that supports critical clinical development, commercial strategy, and regulatory decision-making processes.

About Claritas Rx

Located in South San Francisco, CA, Claritas Rx assists brands catering to rare diseases and specialty medications by eliminating barriers that prevent patients from accessing and adhering to the treatments they require. Their innovative solutions integrate advanced analytics, real-world data, artificial intelligence, and in-line CRM functionalities to enhance patient journey metrics, starting from treatment initiation through refill and beyond.